The Valley Desk

NCT02214121 · Interventional trial

A Pharmacokinetic (PK) and Pharmacodynamic (PD) Dose-ranging Phase II Study of Ticagrelor in Paediatric Patients With Sickle Cell Disease

Overall registry status Completed

Phase 2

Conditions Investigation of Platelet Aggregation in Paediatric Patients With Sickle Cell Disease

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov